13例肺栓塞合并心衰患者术后应用体外膜式氧合治疗的体会  

Clinical management of extracorporeal membrane oxygenation in subacute pulmonary embolism combined heart failure after surgery

作　　者：方艺潭[1] 谷天祥[1] 汤锐[1] 

机构地区：[1]中国医科大学附属第一医院心脏外科

出　　处：《中国心血管病研究》2018年第1期57-59,共3页Chinese Journal of Cardiovascular Research

摘　　要：目的总结成人肺栓塞合并心衰术后应用体外膜式氧合技术（ECMO）治疗的临床经验。方法2013年12月至2017年6月对我院13例成人肺栓塞合并心衰术后行体外膜式氧合技术治疗，其中男性8例、女性5例，年龄37-65岁，采用静脉～动脉转流，辅助期间流量范围1．5-3．0L／min，ECMO辅助时间（82．4±47．1）h，维持活化凝血酶时间（ACT）200-220s。结果13例患者应用ECMO治疗过程中没有出现神经系统并发症，患者均成功撤除ECMO，并康复出院。结论体外膜式氧合技术可以降低肺栓塞取栓术后肺动脉高压，减轻右心负荷，改善气体交换，是治疗肺栓塞术后合并心衰患者的有效手段。Objective To summarize the management experience and result of five adult patients in subacute pulmonary embolism combined heart failure after surgery. Methods The clinical data of 13 patients underwent ECMO from December 2013 to June 2017 were reviewed, including 8 males and 5 females aging from 37-65 years old. All of them were used vein-artery perfusion, the perfusion flow varied form 1.5-3.0 L/min. During EC- MO, their activated clotting time （ACT） was kept 200-220 seconds. Results All of the patients successfully weaned from ECMO. Conclusion ECMO is an effective mechanical assistant therapy for treating subacute pulmonary embolism combined heart failure after surgery.

关 键 词：体外膜式氧合 肺动脉栓塞 心衰 

分 类 号：R654.2[医药卫生—外科学]